Centessa Pharmaceuticals Plc (CNTA)
39.76
+0.06
(+0.15%)
USD |
NASDAQ |
May 20, 16:00
39.76
0.00 (0.00%)
After-Hours: 18:12
Centessa Pharmaceuticals Total Assets (Quarterly) : 641.76M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 29.48B |
| Apellis Pharmaceuticals, Inc. | 1.083B |
| Roivant Sciences Ltd. | 5.225B |
| Eli Lilly & Co. | 116.58B |
| Silence Therapeutics Plc | 115.12M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 154.42M |
| Shareholders Equity (Quarterly) | 487.35M |
| Debt to Equity Ratio | 0.2433 |
| Current Ratio | 9.534 |
| Net Debt Paydown Yield | -0.00% |